Search - tctmd.com

Displaying 361 - 380 of 425

Sort: Relevancy | Date

Presentation TCT 2013

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Presenter: Sachin Goel, Wael El-Mallah, Mobolaji Ige, Supriya Gupta, E Murat Tuzcu, Stephen Ellis, Samir Kapadia

January 31, 2013

Presentation TCT 2013

Efficacy and Safety of Drug-Eluting Balloon Compared to Drug-Eluting Stent for The Treatment of In-Stent Restenosis (ISR)

Presenter: Myung-Hyun Kim, Byeong-Keuk Kim

January 31, 2013

Presentation TCT 2013

Does direct DES stenting reduces restenosis; a randomized comparison of direct stent implantation to stenting with predilation or provisional stenting in elective PCI patients

Presenter: Samer Somi, Wouter Remkes, Jan-Henk Dambrink, Marcel Gosselink, Jan Hoorntje, Harry Suryapranata, Jan Paul Ottervanger, Arnoud van 't Hof

January 31, 2013

Presentation TCT 2013

Cost-effectiveness of paclitaxel-coated balloon angioplasty for treatment of coronary restenosis in bare-metal stents

Presenter: Klaus Bonaventura, Alexander Leber, Christian Sohns, Mattias Roser, Leif-Hendrik Boldt, Wilhelm Haverkamp, Marc Dorenkamp

January 31, 2013

News Conference News TCT 2012

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

October 31, 2012

Presentation TCT 2012

Case 3: Management of Late Restenosis Due to Neoatherosclerosis with Plaque Rupture

Presenter: Robert Byrne

October 26, 2012

Presentation TCT 2012

Update: Everything You Need to Know about Treatment of Restenosis in 2012

Presenter: Alan Yeung

October 26, 2012

Presentation TCT 2012

ISAR-DESIRE 3: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons vs. Paclitaxel-Eluting Stents vs. Balloon Angioplasty for Restenosis of Limus-Eluting Coronary Stents

Presenter: Robert Byrne

October 26, 2012

Presentation TCT 2012

SEDUCE: A Prospective, Randomized Trial of Drug Coated Balloon vs. Everolimus-Eluting Stent in for BMS Restenosis: Optical Coherence Tomography Assessment

Presenter: Tom Adriaenssens

October 25, 2012

Presentation TCT 2012

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from OCT

Presenter: Evelyn Regar

October 25, 2012

Presentation TCT 2012

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from Grayscale and VH-IVUS

Presenter: Akiko Maehara

October 25, 2012

Presentation TCT 2012

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from NIRS

Presenter: James Goldstein

October 25, 2012

Presentation TCT 2012

IVUS-Guided PCI: From Stent Sizing to Predicting Thrombosis and Restenosis

Presenter: Gary Mintz

October 25, 2012

Presentation TCT 2012

IVUS Assessment of Stent Thrombosis and Restenosis

Presenter: Soo-Jin Kang

October 25, 2012

Presentation TCT 2012

First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical)

Presenter: Suhas Lele

October 25, 2012

News Conference News TCT 2012

Positive Results Seen with Angioplasty for Critical Hand Ischemia

October 25, 2012

News Conference News TCT 2012

Paclitaxel-Eluting Balloon Results in High Patency Rate at 1 Year in Below-the-Knee Lesions

October 25, 2012

Presentation TCT 2012

Evaluation and Treatment of In-Stent Restenosis

Presenter: Christoph Kaiser

October 25, 2012

Presentation TCT 2012

Management of Diffuse Restenosis After DES

Presenter: Alaide Chieffo

October 24, 2012

Presentation TCT 2012

Case 2: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

Presenter: Ricardo Costa

October 24, 2012

Advertisement

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Efficacy and Safety of Drug-Eluting Balloon Compared to Drug-Eluting Stent for The Treatment of In-Stent Restenosis (ISR)

Does direct DES stenting reduces restenosis; a randomized comparison of direct stent implantation to stenting with predilation or provisional stenting in elective PCI patients

Cost-effectiveness of paclitaxel-coated balloon angioplasty for treatment of coronary restenosis in bare-metal stents

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

Case 3: Management of Late Restenosis Due to Neoatherosclerosis with Plaque Rupture

Update: Everything You Need to Know about Treatment of Restenosis in 2012

ISAR-DESIRE 3: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons vs. Paclitaxel-Eluting Stents vs. Balloon Angioplasty for Restenosis of Limus-Eluting Coronary Stents

SEDUCE: A Prospective, Randomized Trial of Drug Coated Balloon vs. Everolimus-Eluting Stent in for BMS Restenosis: Optical Coherence Tomography Assessment

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from OCT

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from Grayscale and VH-IVUS

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from NIRS

IVUS-Guided PCI: From Stent Sizing to Predicting Thrombosis and Restenosis

IVUS Assessment of Stent Thrombosis and Restenosis

First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical)

Positive Results Seen with Angioplasty for Critical Hand Ischemia

Paclitaxel-Eluting Balloon Results in High Patency Rate at 1 Year in Below-the-Knee Lesions

Evaluation and Treatment of In-Stent Restenosis

Management of Diffuse Restenosis After DES

Case 2: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content